• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SORIN GROUP CANADA INC. MITROFLOW AORTIC PERICARDIAL HEART VALVE; TISSUE, HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SORIN GROUP CANADA INC. MITROFLOW AORTIC PERICARDIAL HEART VALVE; TISSUE, HEART VALVE Back to Search Results
Model Number LXA
Device Problem Insufficient Information (3190)
Patient Problems Syncope (1610); Cardiac Arrest (1762)
Event Date 12/20/2011
Event Type  Other  
Event Description
The mfr was notified on (b)(6) 2014 that a mitroflow valve (unk serial) was explanted after 1.5 years.Pt presented with syncope, cardiac arrest in cath lab, peak/mean gradients 88 and 52.The above info was obtained from a summary table provided by the surgeon.The serial was obtained from sorin's pt tracking records.
 
Manufacturer Narrative
Device evaluated by mfr.Device was not returned to sorin for investigation.Method: the results of the device history record review confirmed the device met all material, dimensional, and performance requirements at the time of mfr and release.The function test video review confirmed that the valve meets all the established performance criteria.Results code: no definitive results at this time.Conclusion: no conclusion can be drawn at this time as device is unavailable for eval.Additional comments: please note that sorin group reached out to (b)(6) in the us in (b)(6) 2014 after notification of multiple events reported by (b)(6) to obtain more info on the use of the mitroflow valve in pediatric pts.Dr (b)(6) was willing to provide sorin group info on the six pediatric pts that received a mitroflow valve.From the six pts 4 of the valves have been explanted, and 2 are still implanted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITROFLOW AORTIC PERICARDIAL HEART VALVE
Type of Device
TISSUE, HEART VALVE
Manufacturer (Section D)
SORIN GROUP CANADA INC.
burnaby, bc
CA 
Manufacturer (Section G)
SORIN GROUP CANADA INC., MITROFLOW DIV
5005 north fraser way
burnaby, bc V5J 5M1
CA   V5J 5M1
Manufacturer Contact
francesca crovato
5005 north fraser way
burnaby, bc V5J 5-M1
CA   V5J 5M1
4125696
MDR Report Key4284124
MDR Text Key5229696
Report Number3004478276-2014-00024
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P060038
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial
Report Date 05/30/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/19/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Device Expiration Date04/30/2015
Device Model NumberLXA
Device Catalogue NumberLXA21
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? No
Date Device Manufactured05/01/2010
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age11 YR
-
-